Author

Jiansheng Wu

Weill Cornell MedicinePrimary ORCID profile (0000-0002-7941-9722 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Jiansheng WuiD1 paper · Nanjing University of Posts and Telecommunications

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Adrien Le Thomas· 1 shared Alex Hakansson· 1 shared Alvin Gogineni· 1 shared Amy Heidersbach· 1 shared Andrea SboneriD· 1 shared Avi AshkenaziiD· 1 shared Benjamin Haley· 1 shared Brian D. RobinsoniD· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adrien Le Thomas

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNature CommunicationsPeer-reviewedDec 13, 2024

Canonical AREs are tumor suppressive regulatory elements in the prostate

Xuanrong Chen, Michael A. Augello, Deli Liu…·Christopher E. Barbieri

This study identifies canonical AREs as tumor suppressive regulatory elements in prostate cancer, showing their reactivation can induce death in AR+ cancer cells and is linked to better prognosis.

15 citations

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 14, 2018

Disruption of IRE1α through its Kinase Domain Attenuates Multiple Myeloma

Jonathan M Harnoss, Adrien Le Thomas, Scot A Marsters…·Avi Ashkenazi

This study shows that disrupting IRE1α's kinase domain reduces multiple myeloma tumor growth and enhances treatment efficacy, suggesting it as a therapeutic target.

DOI 10.1101/495242

humanbulk RNA-seq

𝕏 PostBluesky